{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:08:25Z","timestamp":1793117305116,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.heliyon.2023.e13020","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T03:41:34Z","timestamp":1674186094000},"page":"e13020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["QSAR modeling and molecular docking studies of 2-oxo-1, 2-dihydroquinoline-4- carboxylic acid derivatives as p-glycoprotein inhibitors for combating cancer multidrug resistance"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8068-7177","authenticated-orcid":false,"given":"M.","family":"Lahyaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4222-1621","authenticated-orcid":false,"given":"A.","family":"Diane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4765-3768","authenticated-orcid":false,"given":"H.","family":"El-Idrissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Saffaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Kandri","family":"Rodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3988-8302","authenticated-orcid":false,"given":"B.","family":"Ihssane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e13020_bib1","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: a synthetic analysis","volume":"4","author":"Plummer","year":"2016","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.heliyon.2023.e13020_bib2","series-title":"Mammalian Drug Efflux Transporters of the ATP Binding Cassette (ABC) Family in Multidrug Resistance: a Review of the Past Decade","author":"Chen","year":"2015"},{"key":"10.1016\/j.heliyon.2023.e13020_bib3","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1124\/pr.113.007518","article-title":"Transporters and drug-drug interactions: important determinants of drug disposition and effects","volume":"65","author":"Konig","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.heliyon.2023.e13020_bib4","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1021\/jm400328s","article-title":"Accurate models for P-gp drug recognition induced from a cancer cell line cytotoxicity screen","volume":"56","author":"Levatic","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2023.e13020_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2174\/1871520615666150129212723","article-title":"Binding cassette (ABC) transporters conferring multi-drug resistance","volume":"15","author":"Li","year":"2015","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.heliyon.2023.e13020_bib6","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1179\/joc.2008.20.6.734","article-title":"Role of ABCB1 and ABCC1 gene induction on survival in locally advanced breast cancer","volume":"20","author":"Atalay","year":"2008","journal-title":"J. Chemother."},{"key":"10.1016\/j.heliyon.2023.e13020_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2023.e13020_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.biopha.2018.02.038","article-title":"Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR","volume":"100","author":"Mohammad","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2023.e13020_bib9","first-page":"113","article-title":"P-glycoprotein transporter in drug development","volume":"15","year":"2016","journal-title":"EXCLI Journal"},{"key":"10.1016\/j.heliyon.2023.e13020_bib10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3892\/or.2012.2153","article-title":"Instability of mRNA expression signatures of drug transporters in chronic myeloid leukemia patients resistant to imatinib","volume":"29","author":"Gromicho","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.heliyon.2023.e13020_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The Amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2023.e13020_bib12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/mol.109.061754","article-title":"Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-\u03b2 in a mouse model of Alzheimer's disease","volume":"77","author":"Hartz","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e13020_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2006.10.007","article-title":"A primer on the mechanics of P-glycoprotein the multidrug transporter","volume":"55","author":"Hennessy","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2023.e13020_bib14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/ci400289j","article-title":"Ligand and structure-based classification models for prediction of P-glycoprotein inhibitors","volume":"54","author":"Klepsch","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.heliyon.2023.e13020_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0928-0987(00)00114-7","article-title":"Multidrug resistance (MDR) in cancer. Mechanisms, reversal-using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs","volume":"11","author":"Krishna","year":"2000","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2023.e13020_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1750-3639.2007.00075.x","article-title":"MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-\u03b2 peptides - implications for the mechanisms of A\u03b2 clearance at the blood-brain barrier","volume":"17","author":"Kuhnke","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.heliyon.2023.e13020_bib17","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1021\/acs.biochem.5b00018","article-title":"Multiple drug transport pathways through human P-glycoprotein","volume":"54","author":"McCormick","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.heliyon.2023.e13020_bib18","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1021\/cr9000226","article-title":"ABC efflux pump-based resistance to chemotherapy drugs","volume":"109","author":"Eckford","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.heliyon.2023.e13020_bib19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bmcl.2008.12.046","article-title":"Identification of 3-amido-4-anilinoquinolines as potent and selective inhibitors of CSF-1R kinase","volume":"19","author":"Scott","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.heliyon.2023.e13020_bib20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00044-010-9522-z","article-title":"An efficient one-pot cyclization of quinoline thiosemicarbazones to quinolines derivatives with 1,3,4-thiadiazole as anticancer and anti-tubercular agents","volume":"21","author":"Marganakop","year":"2010","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.heliyon.2023.e13020_bib21","first-page":"2105","article-title":"A novel 1,2-dihydroquinoline anticancer agent and its delivery to tumor cells using cationic liposomes","volume":"36","author":"Ma","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.heliyon.2023.e13020_bib22","first-page":"2857","article-title":"Biological evaluation of \u03c9-(dialkylamino)alkyl derivatives of 6H-indolo[2,3-b]quinoline\u2013Novel cytotoxic DNA topoisomerase II inhibitors","volume":"25","author":"Godlewska","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1016\/j.heliyon.2023.e13020_bib23","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.2174\/1389557517666170510104954","article-title":"Synthetic methods of quinoline derivatives as potent anticancer agents","volume":"17","author":"Sharma","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e13020_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05067","article-title":"Development and validation of QSPR models for corrosion inhibition of carbon steel by some pyridazine derivatives in acidic medium","volume":"6","author":"El Assiri","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2023.e13020_bib25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5004\/dwt.2018.22198","article-title":"Quantum chemical and QSPR studies of bis-benzimidazole derivatives as corrosion inhibitors by using electronic and lipophilic descriptors","volume":"111","author":"El Assiri","year":"2018","journal-title":"Desalination Water Treat."},{"key":"10.1016\/j.heliyon.2023.e13020_bib26","doi-asserted-by":"crossref","first-page":"133794","DOI":"10.1016\/j.molstruc.2022.133794","article-title":"A quantitative study of the structure-activity relationship and molecular docking of 5.6.7- trimethoxy-N-aryl-2-styrylquinolin-4-amines as potential anticancer agents using quantum chemical descriptors and statistical methods","author":"El Ghalia","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e13020_bib27","first-page":"504","article-title":"Computer aided drug design: an overview","volume":"8","author":"Surabhi","year":"2018","journal-title":"J.D.D.T."},{"key":"10.1016\/j.heliyon.2023.e13020_bib28","series-title":"2-oxo-1, 2-Dihydroquinoline-4-Carboxylic Acid Derivatives as Potent Modulators of ABCB1-Related Drug Resistance of Mouse T-Lymphoma Cells","author":"Baba","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e13020_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033253","article-title":"Characterization of Rhodamine-123 as a tracer dye for use in in vitro drug transport assays","volume":"7","author":"Forster","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e13020_bib30","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1016\/j.bmcl.2016.04.064","article-title":"Identification of Selene-compounds with promising properties to reverse cancer multidrug resistance","volume":"26","author":"Dominguez-Alvarez","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.heliyon.2023.e13020_bib31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bmcl.2017.01.033","article-title":"Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: a confirmation study in a colon cancer MDR cell line","volume":"27","author":"Gajdacs","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e13020_bib32","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1039\/C3AY41907J","article-title":"Principal component analysis","volume":"6","author":"Bro","year":"2014","journal-title":"Anal. Methods"},{"key":"10.1016\/j.heliyon.2023.e13020_bib33","series-title":"3D QSAR in Drug Design: Theory, Methods and Applications","first-page":"523","article-title":"PLS: partial least squares projections to latent structures","author":"Wold","year":"1993"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e13020_bib34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0169-7439(01)00155-1","article-title":"PLS-regression: a basic tool of chemometrics","volume":"58","author":"Wold","year":"2001","journal-title":"Chemometr. Intell. Lab. Syst."},{"key":"10.1016\/j.heliyon.2023.e13020_bib35","series-title":"Some Popular Extensions of Multiple Regression Analyses: a Constructive Critique","first-page":"125","author":"Berk","year":"2003"},{"key":"10.1016\/j.heliyon.2023.e13020_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemolab.2021.104277","article-title":"Comparing CalReg performance with other multivariate methods for estimating selected soil properties from Moroccan agricultural regions using NIR spectroscopy","volume":"211","author":"Reda","year":"2021","journal-title":"Chemometr. Intell. Lab. Syst."},{"key":"10.1016\/j.heliyon.2023.e13020_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2020.118736","article-title":"Predicting soil phosphorus and studying the effect of texture on the prediction accuracy using machine learning combined with near-infrared spectroscopy","author":"Reda","year":"2020","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.heliyon.2023.e13020_bib38","series-title":"A Comparative Study between a New Method and Other Machine Learning Algorithms for Soil Organic Carbon and Total Nitrogen Prediction Using Near Infrared Spectroscopy","author":"Reda","year":"2019"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e13020_bib39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0954-1810(94)00011-S","article-title":"Back-propagation neural networks for modeling complex systems","volume":"9","author":"Goh","year":"1995","journal-title":"Artif. Intell. Eng."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e13020_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/00031305.1992.10475879","volume":"46","year":"1992","journal-title":"Am. Statistician"},{"key":"10.1016\/j.heliyon.2023.e13020_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fnbot.2013.00021","article-title":"Gradient boosting machines, a tutorial","volume":"7","author":"Natekin","year":"2013","journal-title":"Front. Neurorob."},{"key":"10.1016\/j.heliyon.2023.e13020_bib42","series-title":"2-oxo-1, 2-Dihydroquinoline-4-Carboxylic Acid Derivatives as Potent Modulators of ABCB1-Related Drug Resistance of Mouse T-Lymphoma Cells","author":"Baba","year":"2020"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402300227X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402300227X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T10:03:12Z","timestamp":1765360992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402300227X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S240584402300227X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13020","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"QSAR modeling and molecular docking studies of 2-oxo-1, 2-dihydroquinoline-4- carboxylic acid derivatives as p-glycoprotein inhibitors for combating cancer multidrug resistance","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e13020"}}